Related Experiment Video
Updated: Feb 14, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Exon 3 mutations of CTNNB1 drive tumorigenesis: a review
Chao Gao1,2,3, Yingmei Wang1, Russell Broaddus2
1Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Abstract:
The canonical Wnt/β-catenin signaling pathway, an important modulator of progenitor cell proliferation and differentiation, is highly regulated for the maintenance of critical biological homeostasis. Decades of studies in cancer genetics and genomics have demonstrated that multiple genes encoding key proteins in this signaling pathway serve as targets for recurrent mutational alterations. Among these proteins, β-catenin and adenomatosis polyposis coli (APC) are two key nodes. β-catenin contributes in transporting extracellular signals for nuclear programming. Mutations of the CTNNB1 gene that encodes β-catenin occur in a wide spectrum of cancers. These mutations alter the spatial characteristics of the β-catenin protein, leading to drastic reprogramming of the nuclear transcriptional network. Among the outcomes of this reprogramming are increased cell proliferation, enhanced immunosuppression, and disruption of metabolic regulation. Herein we review the current understanding of CTNNB1 mutations, their roles in tumorigenesis and discuss their possible therapeutic implications for cancer.
Insights
Mutations in the CTNNB1 gene, encoding beta-catenin (β-catenin), drive cancer by altering cell behavior and promoting tumor growth. Understanding these CTNNB1 mutations offers potential new cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Genetics
- Cell Signaling
Background:
- The Wnt/β-catenin pathway regulates cell proliferation and differentiation, crucial for biological homeostasis.
- Recurrent mutations in key Wnt/β-catenin pathway genes are common in cancer genetics.
- β-catenin and APC are central proteins in this pathway, with β-catenin mediating signal transduction.
Purpose of the Study:
- To review current knowledge on CTNNB1 mutations.
- To elucidate the role of CTNNB1 mutations in tumorigenesis.
- To discuss potential therapeutic strategies targeting CTNNB1 mutations in cancer.
Main Methods:
- Literature review of cancer genetics and genomics studies.
- Analysis of the impact of CTNNB1 mutations on β-catenin protein structure and function.
- Examination of downstream effects on cellular processes and transcriptional networks.
Main Results:
- CTNNB1 mutations are prevalent across various cancers.
- These mutations lead to altered β-catenin spatial characteristics and nuclear reprogramming.
- Consequences include increased cell proliferation, enhanced immunosuppression, and metabolic dysregulation.
Conclusions:
- CTNNB1 mutations significantly contribute to cancer development and progression.
- Targeting CTNNB1 alterations presents promising therapeutic avenues for cancer treatment.
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview

